期刊文献+

多粘菌素B单克隆抗体对细菌内毒素的拮抗作用 被引量:1

Anti-polymyxin B Monoclonal Antibodies Protect Mice Against Lipopolysaccharide Lethality
下载PDF
导出
摘要 Clone45为IgM类抗多粘菌素B(PMB)单克隆抗体。ELISA抑制试验表明,Clone45与一系列光滑型和粗糙型细菌脂多糖(LPS)以及类脂A能在体外竞争与PMB结合,而与不含类脂A组分的脑膜炎球菌荚膜多糖及合无内毒素活性的类脂A组分的Rh.viridis脂多糖不发生竞争。在盐酸半乳糖致敏的及非致敏的小鼠内毒素休克模型,提前30-120min静脉注射Clone45对随后的致死性内毒素(光滑型E.coliO55:BS和粗糙型S.minnesotaR595LPS)攻击的小鼠具有显著保护作用。Clone45预处理可显著降低LPS诱导的血请肿瘤坏死因子(TNF)水平。这些结果提示,Clone45具有模拟类脂A的表面抗原结构,可作为类脂A的替身和LPS的受体拮抗剂,阻断内毒素诱生炎症介质的致病环节,起到抗内毒素休克的作用。 Clone 45 is an IgM monoclonal antibody directed against polymyxin B(PMB). A vanely of smooth-typedand rough-typed lipololysacchrides (LPS),and lipid A, rather than a capsular polysaccharide from N. meningitidis (whthout lipid A protion) and LPS isolated from Rhodopseudomonas viridis (with non-toxic lipid Aprotion),were found to be able to inhibit the binding of Clone 45 to PMB in ELISA. Administration of Clone 4530-120min prior to LPS injection protected D-galactosamine-sensitized or non-sensitized mice against lethalchallenge of E.colt O55: B5 and S. minnesota R595 LPS and reduced TNFα production. These observations indicate that Clone 45 may have the surface antigenic structure mimicking lipid A .and that Clone 45 may act as lipidA surrogate and LPS receptor antagonist so as to inhibit the production of cytokines (TNF,etc. )responsible forendotoxin shock and thus protect the animals from lethal endotoxemia.
出处 《中国人兽共患病杂志》 CAS CSCD 北大核心 1998年第2期18-23,共6页 Chinese Journal of Zoonoses
关键词 脂多糖 休克 多糖菌素B 败血性 单克隆抗体 lipopolysaccharide, septic shock, polymyxin B, monoclonal antibody, antagonist
  • 相关文献

参考文献2

  • 1苏东辉,中国人兽共患病杂志,1997年,13卷,36页
  • 2黄爱明,国外医学.微生物学分册,1996年,19卷,6期,15页

同被引文献16

  • 1黄爱明,苏东辉.内毒素休克防治的研究进展[J].国外医学(微生物学分册),1996,19(6):15-18. 被引量:9
  • 2谭余庆.抗内毒素药物的研究概况[J].广西医学,1996,18(5):542-542. 被引量:4
  • 3Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res, 2001 ; 7(3) :167.
  • 4Corriveau CC, Danner RL. Antiendotoxin therapies for septic shock. Infect Agents DIS,1993; 2(1):44.
  • 5Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5,a monoclonal antibody to endotoxin. Critcare Med, 1995;23:994.
  • 6The National Committee for the Evaluation of Centoxin. The French national registry of HA- IA (centoxin) in septic shock: a cohort study of 600 patients. Arch Intern Med,1994; 154.. 2484
  • 7Mc Closkey RV, Straube RC, Sanders C, et al: Treatment of Septic shock with human monoclonal antibody HA - IA: a randomized, double- blind, placebo- controlled trial. Ann Intern Med, 1994;121:1.
  • 8Bunnell E, NeumannA, Lyon M, et al. E5531, an endotoxin antagonist, blocks the hyperdynamic and depressant cardio -vascular effects of endotoxins in healthy subjects. Crit Care Med, 1995; 23 (suppl 1):151.
  • 9Bunnelll E, lynn M, Habet K, et al. A lipid A analogue, E5531, blocks endotoxin response in human volunteers with experimental endotoxemia. Crit Care Med, 2000; 28(8): 3084.
  • 10Aoki H, kodama M, Tani T. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B - immobolized fiber. Am J Surg, 1994; 167:412.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部